MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST001689/mwtabprimaryOK200Santosh LamichhaneMass SpectrometryESIEnvironmental Exposurehttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001689Sample Code:DeliverySample Code:3 monthssantosh.lamichhane@utu.fiBreast MilkReversed phase NEGATIVE ION MODE.MetabolomicsWorkbenchMetabolomicsHumanHomo SapiensUniversity of TurkuPE(18:1e/22:4)TG(52:0)LPC(20:4)PE(O-38:5) or PE(P-38:4)PE(16:0/20:4)_2TG(16:1/18:1/12:0)TG(16:0/16:0/16:0)SM(31:1)PI (38:3) /(18:0/20:3)Cer(d18:1/14:0)PC(O-34:3)PC(33:0)PE(16:0/20:4)TG(56:5)PC(37:4)TG(51:4)HexCer(d18:1/22:0)TG (53:3)PS (39:6) /(17:0/22:6)TG(50:0)_2DG(18:1/18:1))LPC(20:5)PE(O-38:5) or PE(P-38:4)_2PE(O-38:5) or PE(P-38:4)_3PC(36:4)_2PC(36:4)_3TG(56:6)PC(33:1)TG(52:2)TG(51:2)_2PG (O-39:0) / (O-20:0/19:0)PC (42:8) / (20:3/22:5)PE(38:5)_1PE(18:1e/22:6)TG(51:2)_3Cer(d35:1)TG(18:0/18:0/18:0)PE(P-16:0/18:2)PC(37:2)PE(18:0/20:4)_2PI(18:0/20:4)PC(32:1)PC(O-38:5)TG(52:3)PC(36:5)SM(d38:2)PE(P-16:0/22:6)TG(45:0)PC(38:4)_2PE(O-16:0/18:1)DG (36:3)SM(d33:1)LacCer(d18:1/16:0)PC(O-34:2)PC(16:0/18:1)TG(56:6)_2LPC(14:0)PC(32:2)TG(52:4)TG(54:5)_2PC(37:3)PC(O-38:6)TG(49:3)PE(18:0/20:4)SM(d41:2)SM(d18:1/24:0)TG(50:1)_3PI (44:4) / (22:4/22:0)PC(38:3)_2TG(50:1)_2Cer(d18:1/24:1)TG(16:0/16:0/12:0)PC(36:3)PC(36:5)_2TG(18:2/18:1/18:1)PS (41:5) /(22:4/19:1)TG(56:9)TG (54:1) / TG (16:0/22:1/16:0)TG(52:5)TG(18:1/18:2/18:2)_2TG(18:2/22:5/16:0)TG (56:4) / TG (20:1/16:0/20:3)TG(O-50:1) or TG(P-50:0)TG(53:2)TG(49:2)SM (39:2) / (18:2/21:0)SM(d41:1)Cer(d36:1)SM(d35:1)TG(58:6)_2TG(38:1)PC (39:0) / (13:0/26:0)Cer(d42:1)TG(52:6)SM(d18:2/14:0)PC (36:4) /(18:3/18:1)PE(18:0/22:6)_2TG(53:3)PC(O-38:4)LPC(18:2)PC(36:4)TG(18:2/18:2/18:2) or TG(18:3/18:2/18:1)_2TG(52:5)_2TG(18:1/12:0/18:1) or TG(18:2/16:0/14:0)PC(18:0p/18:1(9Z))SM(d18:0/14:0)TG(49:1)PC(40:7)TG(53:5)_2DG(36:4)PC(36:1)PE(P-18:0/18:2)TG(54:4)_2TG(53:4)SM (37:1) / (18:1/19:0)PE(P-18:0/22:6)TG(48:3)TG (56:3) / TG ( 18:0/20:3/18:0)TG (52:0)PC(40:8)TG(49:0)PC(36:2)TG(14:0/18:1/18:1)TG(58:6)TG (49:3) / (15:0/18:2/16:1)PC(O-36:4)_2Cer(d18:1/20:0)PE(P-18:0/18:1)TG (48:2) / (14:1/16:1/18:0)TG(53:5)SM(d40:1)PE(O-16:0/22:6) or PE(P-18:0/20:5)LPC(18:0)TG(O-52:1) or TG(P-52:0)TG(54:2)SM (d42:3) /(d18:2/24:1)TG(18:2/18:2/18:2) or TG(18:3/18:2/18:1)PE(16:0/22:6)TG (46:2) / (16:1/14:0/16:1)PC(30:0)PC(O-32:0)PC(40:5)Cer(d18:1/23:0)CE(18:1)LPC(22:6)PC(O-36:5)TG(18:0/18:1/20:4)PC(16:0/16:0)TG(54:3)SM (d39:1) / (d16:1:23:0)SM(d42:2)SM (40:2) / (18:1/22:1)TG(47:2)_2PC(O-38:4)_2SM(d36:2)PC(40:6)PC(O-32:1)TG(48:1)CE(18:2)TG(56:4)_2PC(35:3)TG(16:0/18:2/18:2)PC (38:2) / (14:1/24:1)TG(58:8)TG(54:4)DG(36:3)TG(37:0)TG(49:3)_2PE(38:5)SM(d42:1)TG(50:0)PE(18:2e/22:6)PS (41:4)TG(16:0/22:5/18:1) or TG(20:4/18:1/18:1)PE(P-18:0/22:5) + PE(P-20:1/20:4)SM(d36:1)TG(48:0)PG (O-41:0) / (O-20:0/21:0)TG(58:10)_2TG(50:3)_2TG(O-52:2) or TG(P-52:1)PC(34:3)PC(O-36:3)Cer(d18:1/16:0)TG(16:0/18:2/18:3)SM(d18:1/12:0)TG(58:9)PE(16:0/18:1)TG(54:5)PE(18:1/18:2)TG(50:1)HexCer(d18:1/24:0)PC(40:4)SM(d36:0)TG(58:10)Cer(d18:1/24:0)PE(P-16:0/20:4)TG(47:2)PC(O-36:4)PC(35:1)TG(54:6)TG(54:2)_2TG(50:2)TG(51:4)_2PC(O-38:5)_2SM(d18:0/16:0)TG(47:1)TG(60:7)CE fragmentLPC(16:1)TG(54:7)PE(P-16:0/20:4)_2PC(38:5)PE(18:0/22:6)TG(50:3)TG(14:0/16:0/18:1)PC(38:6)_2Cer(d18:1/22:0)PE(18:0/18:1)PC(40:6)_2TG(47:0)TG(18:1/18:2/18:2)PC (38:1)PC(34:2)PE(16:0/18:2)TG (48:4)TG(56:2)PE(16:1e/20:3)PC(38:6)LPC(16:0)TG(18:2/18:1/16:0)TG(54:7)_2HexCer(d18:1/23:0)TG(51:1)TG(18:0/18:1/20:4)_2TG(18:1/18:1/22:6)Cer(d36:1)_2PC(35:3)_2PC(16:0e/18:1(9Z))SM(d32:1)SM(d18:1/16:0)DG(34:2)TG(56:3)PC(38:3)TG(50:5)LPC(20:3)PC(O-34:3)_2TG(51:2)PC(P-18:0/22:6)TG(18:1/18:1/18:1)TG (51:3) / TG (15:1/18:1/18:1)TG (46:0) / (14:0/16:0/16:0)SM(d16:1/18:1) or SM(d18:2/16:0)TG(16:0/18:2/22:6)PC(18:0/18:0)PE(16:1e/20:5)TG(56:4)Cer (d40:1) / (d18:1/22:0)PC(36:2)_2TG(51:3)PC(38:4)mamma, Mass Spectrum Analysis, study, mammary region, Mass Spectrum, Breasts, Infants, Analyses, Birth, PFAS, Blood, mammary part of chest, Liquid Chromatography, Spectrometry, Parturitions, Spectrum Analyses, Blood Serum, Serum, PURL, Spectrum Analysis, FGARAT, Milk, Spectroscopy, mammary gland milk, Births, Cow Milk, Cow, TOF, Cow's Milk, Mass, Mass., Cow's, Analysis, FGAR-AT, Childbirths, Serums, Mass Spectrum Analyses, FGAMS, Mass Spectroscopy, Childbirthbackward, reversed.mamma, Cow's., mammary part of chest, lipids, mammary region, mammary gland milk, Breasts, Cow Milk, Cow, Cow's Milk, Lipid, Milk0.00.00.00.00.0falseExposure to per- and polyfluoroalkyl substances associates with altered lipid profile of breast milk (Part 1)In this mother-infant study (n=44) we investigated the levels of PFAS in maternal serum and detailed lipidomic profile in breast milk at birth and at three months using ultra high performance liquid chromatography combined with quadrupole-time-of-flight mass spectrometry.Mon Feb 08 00:00:00 GMT 2021ST0016899606